Jim Simons United Therapeutics Corp Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in United Therapeutics Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 2,151,714 shares of UTHR stock, worth $590 Million. This represents 0.78% of its overall portfolio holdings.
Number of Shares
2,151,714
Previous 2,170,214
0.85%
Holding current value
$590 Million
Previous $477 Million
3.58%
% of portfolio
0.78%
Previous 0.74%
Shares
22 transactions
Others Institutions Holding UTHR
# of Institutions
562Shares Held
43.1MCall Options Held
501KPut Options Held
529K-
Black Rock Inc. New York, NY5.57MShares$1.53 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.68MShares$1.28 Billion0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.41MShares$936 Million0.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$784 Million7.91% of portfolio
-
State Street Corp Boston, MA1.94MShares$531 Million0.02% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $12.5B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...